MDM4 is a rational target for treating breast cancers with mutant p53

Panimaya Jeffreena Miranda; Daniel Buckley; Dinesh Raghu; Jia-Min B Pang; Elena A Takano; Reshma Vijayakumaran; Amina FAS Teunisse; Atara Posner; Tahlia Procter; Marco J Herold; Cristina Gamell; Jean-Christophe Marine; Stephen B Fox; Aart Jochemsen; Sue Haupt; Ygal Haupt

Journal article

MDM4 is a rational target for treating breast cancers with mutant p53

Panimaya Jeffreena Miranda, Daniel Buckley, Dinesh Raghu, Jia-Min B Pang, Elena A Takano, Reshma Vijayakumaran, Amina FAS Teunisse, Atara Posner, Tahlia Procter, Marco J Herold, Cristina Gamell, Jean-Christophe Marine, Stephen B Fox, Aart Jochemsen, Sue Haupt, Ygal Haupt

The Journal of Pathology | WILEY | Published : 2017

DOI: 10.1002/path.4877

University of Melbourne Researchers

Susan Haupt Author Clinical Pathology

Marco Herold Author Medical Biology (W.E.H.I.)

Stephen Fox Author The Sir Peter MacCallum Department of Oncology

Ygal Haupt Author The Sir Peter MacCallum Department of Oncology

Related Projects (3)

New role for the E3 ligase E6AP in the control of cell motility and invasion

Cell motility and invasion are fundamental process in normal cellular functions, however, when deregulated they can lead to metastatic cance..

RESTORATION OF TUMOUR SUPPRESSION IN PROSTATE CANCER BY TARGETING THE UBIQUITIN PROTEASOME SYSTEM

NOVEL APPROACH TO TREATMENT OF HER2+ BREAST CANCERS WITH POOR PROGNOSIS

Grants

Awarded by NHMRC

Awarded by CCV

Awarded by NBCF

Awarded by National Breast Cancer Foundation

Funding Acknowledgements

This work was supported by an NHMRC project grant (1049179) and an NHMRC Fellowship to YH (9628426), by a CCV grant (1085154), and by an innovator grant from NBCF (IN-16-042).